Skip to main content

Table 1 Descriptive statistics of study cohort followed from 6–24 months of age

From: Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children

Characteristic

No chemoprevention

Monthly DHA/PQ

Number of children followed

89

87

Female gender, n (%)

41 (46)

46 (54)

Location of residence, n (%)

 Rural, n (%)

85 (95.5)

79 (90.8)

 Town, n (%)

2 (2.3)

6 (6.9)

 Unknown, n (%)

2 (2.3)

2 (2.3)

Maternal age in years

 16 to <22, n (%)

30 (33.7)

25 (28.7)

 22 to <36, n (%)

53 (59.6)

53 (60.9)

 36 to <45, n (%)

6 (6.7)

9 (10.3)

House construction

 Non-ideal home

81 (91.0)

75 (86.2)

 Ideal home

6 (6.7)

10 (11.5)

 Unknown

2 (2.3)

2 (2.3)

Primary caregiver education

 Primary school or less, n (%)

69 (77.5)

74 (85.1)

 More than primary school, n (%)

18 (20.2)

11 (62.5)

 Unknown, n (%)

2 (2.3)

2 (2.3)

  1. DHA/PQ dihydroartemisinin-piperaquine